Advertisement

Colitis ulcerosa: Konservative Therapie

  • B. Miller
Conference paper
Part of the Interdisziplinäre Gastroenterologie book series (GASTROENTEROLOG)

Zusammenfassung

Die konservative Behandlung des Patienten mit Colitis ulcerosa darf sich nicht nur auf die medikamentöse Therapie beschränken, sondern muß auch die lebenslange ärztliche Überwachung und die psychische Betreuung einschließen. Da sich diese drei Aspekte in der praktischen Führung des Kolitiskranken nicht trennen lassen, wenn jeder von ihnen optimal verwirklicht werden soll, sind die damit verbundenen ärztlichen Aufgaben in der Regel auch nicht teilbar und ohne weiteres an Spezialisten delegierbar. Das schließt natürlich nicht aus, daß der Arzt, in dessen Hand die Betreuung von Kolitispatienten liegt, bei besonderen diagnostischen oder therapeutischen Problemen konsiliarisch den Rat von spezialisierten und entsprechend fachkompetenten Kollegen einholt.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Azad Khan AK, Howes DT, Piris J, Truelove SC (1980) Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut 21:232PubMedCrossRefGoogle Scholar
  2. 2.
    Bartalsky A (1982) Salicylazobencoic acid in ulcerative colitis. Lancet I:960CrossRefGoogle Scholar
  3. 3.
    Birnie GG, McLeod TIF, Watkinson G (1981) Incidence of sulphasalazine-induced male infertility. Gut 22:452PubMedCrossRefGoogle Scholar
  4. 4.
    Bläker F, Schäfer KH, Lassrich MA (1978) Colitis ulcerosa und Colitis granulomatosa im Kindesalter. Monatsschr Kinderheilkd 126:411PubMedGoogle Scholar
  5. 5.
    Buckell NA, Gould SR, Day DW, Lennard-Jones JE, Edwards AM (1978) Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis. Gut 19:1140PubMedCrossRefGoogle Scholar
  6. 6.
    Davies PS, Rhodes J, Councell B, Evans BK (1980) Maintenance of remission in ulcerative colitis. Effect of an orally absorbed mast cell stabilizer. Am J Gastroenterol 74:150PubMedGoogle Scholar
  7. 7.
    Dew MJ, Hughes PJ, Harries AD, Williams G, Evans BK, Rhodes J (1982) Oral 5-amino salicylic acid for the maintenance of remission in ulcerative colitis: A controlled trial. Gut 23: A892Google Scholar
  8. 8.
    Dissanayake AS, Truelove SC (1973) A controlled therapeutical trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine. Gut 14:923PubMedCrossRefGoogle Scholar
  9. 9.
    Dronfield MW, Langman MJS (1978) Comparative trial of sulphasalazine and oral sodium cromoglycat in the maintenance of remission in ulcerative colitis. Gut 19:1136PubMedCrossRefGoogle Scholar
  10. 10.
    Elsborg L, Larsen L (1979) Folate deficiency in chronic inflammatory bowel diseases. Scand J Gastroenterol 14:1019PubMedGoogle Scholar
  11. 11.
    Fahrländer H (1980) Salazosulfapyridin in der Schwangerschaft? Dtsch Med Wochenschr 105:1729PubMedCrossRefGoogle Scholar
  12. 12.
    Fitcher JH (1975) Amyloidosis and granulomatous ileocolitis. Regression after surgical removal of the involved bowel. Engl J Med 292:352CrossRefGoogle Scholar
  13. 13.
    Franklin JL, Rosenberg JH (1973) Impaired folic acid absorption in inflammatory bowel disease: Effects of salicylazosulfapyridine (Azulfidine). Gastroenterology 64:517PubMedGoogle Scholar
  14. 14.
    Gage TP (1982) Screening colonoscopy or colectomy to prevent cancer in colitis. A decision-analytic approach (Abstract). Gastroenterology 82:1062Google Scholar
  15. 15.
    Greenstein AJ, Janowitz HD, Sachar DB (1976) The extra-intestinal complications of Crohn’s disease and ulcerative colitis: A study of 700 patients. Medicine (Baltimore) 55:401CrossRefGoogle Scholar
  16. 16.
    Holdsworth CD (1981) Sulphasalazine desensitisation. Br Med J 282:110CrossRefGoogle Scholar
  17. 17.
    Ijaiya K, Dick W, Heimann G (1976) Die Therapie der Colitis ulcerosa im Kindesalter. Therapiewoche 26:5176Google Scholar
  18. 18.
    Järnerot G (1981) Übertritt von Sulfasalazine und Sulfapyridin in die Muttermilch und durch die Plazentarschranke sowie der Einfluß der beiden Substanzen auf die Bilirubinbindung an Albumin. Z Gastroenterol [Suppl] 19:27Google Scholar
  19. 19.
    Järnerot G, Into-Malmberg MB (1979) Sulphasalazine treatment during breast feeding. Scand J Gastroenterol 14:869PubMedCrossRefGoogle Scholar
  20. 20.
    Järnerot G, Into-Malmberg MB, Esbjörner E (1981) Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites. Scand J Gastroenterol 16:693PubMedCrossRefGoogle Scholar
  21. 21.
    Jewell DP, Truelove SC (1974) Azathioprine in ulcerative colitis: Final report on controlled therapeutic trial. Br Med J IV:627CrossRefGoogle Scholar
  22. 22.
    Jewell DP, Truelove SC (1981) Disodium azodisalicylate in ulcerative colitis. Lancet II:1168CrossRefGoogle Scholar
  23. 23.
    Katzka I, Brody RS, Morris E, Katz S (1983) Assessment of colorectal cancer risk in patients with ulcerative colitis: Experience from a private practice. Gastroenterology 85:22PubMedGoogle Scholar
  24. 24.
    Kinlen LJ, Sheil AGR, Peto J, Doll R (1979) Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J II:1461CrossRefGoogle Scholar
  25. 25.
    Kirk AP, Lennard-Jones JE (1982) Controlled trial of azathioprine in chronic ulcerative colitis. Br Med J 284:1291CrossRefGoogle Scholar
  26. 26.
    Kirschner BS, Voinchet O, Rosenberg IH (1978) Growth retardation in inflammatory bowel disease. Gastroenterology 75:504PubMedGoogle Scholar
  27. 27.
    Korelitz BI, Glass JL, Wisch N (1973) Long-term immunosuppressive therapy of ulcerative colitis. Dig Dis Sci 18:317CrossRefGoogle Scholar
  28. 28.
    Korelitz BI, Glass JL, Wisch N (1978) Long-term observation of children with ulcerative colitis treated with an immunosuppressive drug (6-mercaptopurine). Gastroenterology 72:1083Google Scholar
  29. 29.
    Korelitz BI, Present DH, Rubin PH, Fochios SE (1982) Desensitisation to sulfasalazine in allergic patients with IBD: An important modality. Gastroenterology 82:1104Google Scholar
  30. 30.
    Miller B (1980) Nebenwirkungen der Therapie mit Salazosulfapyridin. Dtsch Med Wochenschr 105:1596PubMedCrossRefGoogle Scholar
  31. 31.
    Miller B (1981) Hämatologische Nebenwirkungen von Sulfasalazine. Z Gastroenterol [Suppl] 19:29Google Scholar
  32. 32.
    Mörl M (1981) Begleitkrankheiten von Colitis ulcerosa und Morbus Crohn. Med Klin 76:265PubMedGoogle Scholar
  33. 33.
    Mogadam M, Dobbins WO, Korelitz BI, Ahmed SW (1981) Pregnancy in inflammatory bowel disease: Effect of sulphasalazine and corticosteroids on fetal outcome. Gastroenterology 80:72PubMedGoogle Scholar
  34. 34.
    Morin CL, Roulet M, Roy CC, Weber A (1980) Continuous elemental enteral alimentation in children with Crohn’s disease and growth failure. Gastroenterology 79:1205PubMedGoogle Scholar
  35. 35.
    O’Morain CA, Smethurst P, Hudson E, Levi AJ (1982) Further studies on sulphasalazine-induced male infertility. Gastroenterology 82:1140Google Scholar
  36. 36.
    Otto HF, Gebbers JO (1978) Präcanceröse Epitheldysplasien bei Colitis ulcerosa. Virchows Arch [Pathol Anat] 377:259CrossRefGoogle Scholar
  37. 37.
    Penn J (1978) Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 83:492PubMedGoogle Scholar
  38. 38.
    Powell-Tuck J, Brown RI, Chambers TJ, Lennard-Jones JE (1980) Controlled trial of alternate day prednisolone as a maintenance treatment for ulcerative colitis in remission. Gut 21:444Google Scholar
  39. 39.
    Reisenauer AM, Halsted CH (1981) Human jejunal brush border folate conjugase. Characteristics and inhibition by salicylazosulfapyridine. Biochim Biophys Acta 659:62PubMedGoogle Scholar
  40. 40.
    Riddell RH (1980) Dysplasia in inflammatory bowel disease. Clin Gastroenterol 9/2:439PubMedGoogle Scholar
  41. 41.
    Riis P (1980) A critical survey of controlled studies in the treatment of ulcerative colitis and Crohn’s disease. Clin Gastroenterol 9/2:351PubMedGoogle Scholar
  42. 42.
    Riis P, Anthonisen P, Wulff HR, Folkenborg O, Bonnevie O, Binder V (1973) The prophylactic effect of salazosulphapyridine in ulcerative colitis during longterm treatment. A double-blind trial of patients asymptomatic for one year. Scand J Gastroenterol 8:71PubMedGoogle Scholar
  43. 43.
    Rosenberg JL, Wall AJ, Levin B, Binder HJ, Kirsner JB (1975) A controlled trial of azathioprine in the management of chronic ulcerative colitis. Gastroenterology 69:96PubMedGoogle Scholar
  44. 44.
    Selhub J, Dhar GJ, Rosenberg JH (1978) Inhibition of folate enzymes by sulfasalazine. J Clin Invest 61:221PubMedCrossRefGoogle Scholar
  45. 45.
    Sharfstein SS, Sack DS, Fauci AS (1982) Relationship between alternate-day corticosteroid therapy and behavioural abnormalities. JAMA 248:2987PubMedCrossRefGoogle Scholar
  46. 46.
    Taffet SL, Das KM (1982) Desensitization of patients with inflammatory bowel disease to sulphasalazine. Am J Med 73:520PubMedCrossRefGoogle Scholar
  47. 47.
    Toovey S, Hudson E, Hendry WF, Levi AJ (1981) Sulphasalazine and male infertility: Reversibility and possible mechanism. Gut 22:445PubMedCrossRefGoogle Scholar
  48. 48.
    Truelove SC (1973) Medical aspects of ulcerative colitis in childhood. Proc R Soc Med 66:1032PubMedGoogle Scholar
  49. 49.
    Truelove SC, Jewell DP (1974) Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet I:1067CrossRefGoogle Scholar
  50. 50.
    Willoughby CP, Truelove SC (1980) Ulcerative colitis and pregnancy. Gut 21:469PubMedCrossRefGoogle Scholar
  51. 51.
    Willoughby CP, Heyworth MF, Piris J, Truelove SC (1979) Comparison of disodium cromoglycate and sulphasalazine as maintenance therapy for ulcerative colitis. Lancet I:119CrossRefGoogle Scholar
  52. 52.
    Willoughby CP, Piris J, Truelove SC (1980) The effect of topical N-acetyl-5-aminosali-cylic acid in ulcerative colitis. Scand J Gastroenterol 15:715PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • B. Miller

There are no affiliations available

Personalised recommendations